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A nursery study was conducted at the KSU 
Segregated Early-Weaning Facility to evaluate 
the effect of dietary arabinogalactan on 
weanling pig performance. Arabinogalactan is 
a water-soluble proteoglycan/polysaccharide, 
most commonly harvested from the bark of 
the Western Larch (Larix occidentalis) tree, 
which has demonstrated neutraceutical proper-
ties in a limited number of studies with dogs 
and foals. A total of 288 pigs (initially 14.9 lb) 
were used in the 35-d experiment. Pigs were 
blocked by weight and randomly allotted to 
one of eight dietary treatments fed throughout 
Phase 1 (d 0 to 14) and Phase 2 (d 14 to 28), 
followed by a common diet during Phase 3 (d 
28 to 35). Four levels of arabinogalactan (0, 
0.05, 0.10, and 0.20%) were included in either 
a negative or positive control diet in a 2 × 4 
factorial to form the eight dietary treatments. 
The negative control diet was a corn-soybean 
meal based diet without feed-grade antibiotics. 
The positive control diet was identical to the 
negative control, but contained a feed-grade 
antibiotic (Neo-Terramycin with 140 g of 
neomycin and 140 g of oxytetracycline per 
ton). The common diet fed during Phase 3 did 
not contain arabinogalactan, but did contain a 
feed-grade antibiotic (Neo-Terramycin). From 
d 0 to 14 (Phase 1), ADG, ADFI, and d 14 
weight decreased (linear, P<0.05) with in-
creasing level of arabinogalactan in the diet. 
Also, pigs fed the positive control diet were 
heavier (P<0.05) on d 14 than those fed the 
negative control. During Phase 2 (d 14 to 28) 
and for the overall treatment period (d 0 to 
28), ADG, ADFI, and d 28 weight were im-
proved (P<0.01) for pigs fed the positive con-
trol diet compared with pigs fed the negative 
control. Due to the reduction in ADFI at the 
highest level (0.20%) of arabinogalactan, 
ADFI decreased (linear, P<0.05) from d 0 to 
28 with increasing arabinogalactan. From d 28 
to 35 (Phase 3), when all pigs were fed a 
common diet, ADG and F/G were poorer for 
pigs previously fed the positive control. Over-
all (d 0 to 35), ADG tended to be improved 
(P<0.07), and ADFI and d 35 weight were 
improved (P<0.05) for pigs fed the positive 
control, but F/G was slightly poorer (P<0.05) 
than for pigs fed the negative control. A re-
duction (linear, P<0.05) in ADFI was ob-
served for pigs fed increasing arabinogalactan.  
In conclusion, the addition of arabinogalactan 
to weanling pig diets did not improve growth 
performance with the high level (0.20%) re-
sulting in reduced ADFI. However, ADG, 
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ADFI, and d 35 weight were improved by in-
cluding a feed-grade antibiotic in the Phase 1 
and Phase 2 diets. 
 




There is increasing public concern about 
the use of sub-therapeutic levels of feed-grade 
antibiotics in food animal production.  The 
judicious use of sub-therapeutic (or more 
commonly “growth promoter”) levels of anti-
biotics in food animal production has served 
to improve animal health, welfare, and per-
formance/production efficiency.  Most often, 
the use of these feed-grade antibiotics coin-
cides with periods of increased stress, such as 
weaning. 
 
As an alternative to feed-grade antibiotics, 
there is increasing interest in identifying suit-
able nutraceutical compounds. Nutricines are 
“natural” compounds found in various food-
stuffs in trace amounts, with properties that 
may improve health and immune function but 
lack an established requirement. An increasing 
understanding of potential nutraceutical com-
pounds that may enhance immunity and 
health, and improve the ability to cope with 
periods of increased stress has stimulated in-
terest in identifying suitable antibiotic re-
placements.  Few nutraceuticals, however, 
have been evaluated in studies measuring 
animal performance. 
 
Arabinogalactan is a naturally occurring, 
water-soluble proteoglycan/polysaccharide 
that is not generally found in foodstuffs com-
monly fed to domesticated pigs. A few ex-
periments with dogs and young foals have 
identified improvements in the digestive 
health and immune function of animals sup-
plemented with arabinogalactan in their diet. 
Weanling pigs are particularly vulnerable to 
enteric diseases and digestive upset, and these 
contribute significantly to losses in growth 
 
performance during the nursery period. A 
large portion of the “growth promoter” levels 
of feed-grade antibiotics used in the swine in-
dustry are used during this period due to their 
demonstrated efficacy in nursery pigs. There-
fore, the objective of this experiment was to 
evaluate the influence of dietary arabinogalac-





Procedures used in this experiment were 
approved by the Kansas State University 
Animal Care and Use Committee.  The project 
was conducted at the KSU Segregated Early-
Weaning Facility. Pens had steel ‘tri-bar’ 
flooring and provided approximately 3 ft2 per 
pig. Each pen was equipped with a four-hole, 
dry, self-feeder and one cup waterer, provid-
ing ad libitum access to feed and water.  The 
facility was a mechanically ventilated room 
with a pull-plug manure storage pit under-
neath the pens’ mesh flooring. 
 
A total of 288 pigs were weaned at an av-
erage of 14.9 lb and 21 d of age. Pigs were 
blocked by weight and randomly allotted to 
one of the eight dietary treatments with eight 
pens per treatment. Each pen contained either 
4 or 5 pigs. Two control diets were used. The 
negative control diet did not contain any feed-
grade antibiotics, while the positive control 
diet contained a feed-grade antibiotic (Neo-
Terramycin with 140 g of neomycin and 140 g 
of oxytetracycline per ton). Arabinogalactan 
(Larafeed® AG; to provide 0, 0.05, 0.10 and 
0.20% arabinogalactan) was added to each 
control diet at the expense of corn starch to 
achieve the eight dietary treatments. Experi-
mental diets were fed in meal form and main-
tained throughout two dietary phases (Table 
1). Phase 1 diets were fed from d 0 to 14 and 
Phase 2 diets were fed from d 14 to 28.  All 
pigs were fed a common diet that contained a 
feed-grade antibiotic (Neo-Terramycin with 
140 g of neomycin and 140 g of oxytetracy- 
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cline per ton) during Phase 3 (d 28 to 35). Pigs 
and feeders were weighed on d 0, 7, 14, 21, 
28, and 35 post-weaning to determine the re-
sponse criteria of ADG, ADFI, and F/G. 
For the overall treatment period (d 0 to 
28), ADG and ADFI were improved for pigs 
fed the positive control. Because of the lower 
ADFI for pigs fed the diet containing the 
highest level (0.20%) of arabinogalactan, 
ADFI decreased linearly (P<0.05) with in-
creasing arabinogalactan. 
 
Data were analyzed as a randomized com-
plete block design using the PROC MIXED 
procedure of SAS with pen as the experimen-
tal unit.  Linear and quadratic polynomial con-
trasts were used to determine the effects of 
increasing arabinogalactan. 
 
From d 28 to 35 (Phase 3), when all pigs 
were fed a common diet, ADG and F/G were 
poorer (P<0.01) for pigs previously fed the 
positive control diet.   
Results  
 Overall (d 0 to 35), ADG tended to be im-
proved (P<0.07) for pigs fed the positive con-
trol. Also, ADFI and d 35 weight were im-
proved (P<0.05) for pigs fed the positive con-
trol, but F/G was slightly poorer (P<0.05). A 
reduction (linear, P<0.05) in ADFI was ob-
served for pigs fed increasing arabinogalactan, 
primarily at the highest level (0.20%). 
There were no interactions (P>0.10) be-
tween the control diet and arabinogalactan 
(Tables 2 and 3). For the d 0 to 14 (Phase 1) 
period, ADG, ADFI, and d 14 weight de-
creased (linear, P<0.05) with increasing ara-
binogalactan in the diet. This was primarily 
due to the large reductions observed at the 
highest level fed (0.20%). Also, pigs fed the 
positive control diet had heavier (P<0.05) d 14 
weights than those fed the negative control. 
  
In conclusion, the addition of arabinoga-
lactan to weanling pig diets did not improve 
growth performance. In fact, feeding the high-
est level (0.20%) resulted in reduced perform-
ance. However, ADG, ADFI, and d 35 weight 
were improved by including a feed-grade an-
tibiotic in the Phase 1 and Phase 2 diets. 
 
During Phase 2 (d 14 to 28), ADG, ADFI, 
and d 28 weight of pigs fed the positive con-
trol diet were improved compared with pigs 








Table 1.  Composition of Experimental Dietsa,b,c





Corn 50.67 59.85 58.01 
Soybean meal (46.5% CP) 30.13 35.05 34.85 
Select menhaden fish meal 3.75 - - 
Spray-dried edible whey 10.00 - - 
Corn starch 1.17 1.17 - 
Soybean oil 1.00 - 3.00 
Monocalcium P (21% P) 1.20 1.50 1.20 
Limestone 0.75 1.10 0.93 
Salt 0.35 0.35 0.35 
L-lysine HCl 0.30 0.30 0.30 
DL-methionine 0.13 0.13 0.15 
L-threonine 0.15 0.15 0.11 
Vitamin premix 0.25 0.25 0.25 
Trace mineral premix 0.15 0.15 0.15 
Antibioticc - - 0.70 
Total 100.00 100.00 100.00 
  
Calculated analysis  
Total lysine, % 1.55 1.45 1.44 
True digestible amino acids    
  Lysine, % 1.41 1.31 1.30 
  Isoleucine:lysine ratio, % 60 63 62 
  Leucine:lysine ratio, % 121 129 128 
  Methionine:lysine ratio, % 33 33 35 
  Met & Cys:lysine ratio, % 56 58 59 
  Threonine:lysine ratio, % 63 64 62 
  Tryptophan:lysine ratio, % 17 18 18 
  Valine:lysine ratio, % 66 69 69 
Protein, % 22.40 21.90 21.60 
ME, kcal/lb 1,514 1,492 1,560 
TID lysine: ME ratio, g/Mcal 4.22 3.98 3.78 
Ca, % 0.81 0.73 0.71 
P, % 0.70 0.65 0.65 
Available P, % 0.40 0.32 0.33 
aThe positive control contained a feed-grade antibiotic (140 g/ton of Neomycin and 140 g/ton of 
Oxytetracycline) at the expense of corn starch, but was otherwise identical to the negative control. 
bLarafeed® AG (to provide 0, 0.05, 0.10 and 0.20% arabinogalactan) was added to the basal diets 
at the expense of corn starch. 
cProvided 140 g/ton of Neomycin and 140 g/ton of Oxytetracycline. 
Table 2.  Growth Performance of Nursery Pigs Fed Increasing Arabinogalactan – Interactive Meansa,b,c
     P < 
 Negative Control Positive Control   Negative vs  Arabinogalactan 
Item   Arabinogalactan, % 0 0.05 0.10 0.20 0 0.05 0.10 0.20 SE Mean Positive Arabinogalactan Linear Quadratic
D 0 to  14              
  ADG, lb 0.34 0.37 0.32 0.31 0.38 0.38 0.41 0.31 0.04 0.08 0.10 0.05 - 
  ADFI, lb 0.43 0.43 0.39 0.39 0.44 0.44 0.48 0.39 0.03 0.08 0.06 0.02 - 
  F/G 1.32 1.19 1.28 1.25 1.19 1.20 1.16 1.60 0.15 - - - - 
D 14 to 28              
  ADG, lb 1.00 0.98 1.02 1.01 1.15 1.13 1.21 1.07 0.05 0.01 - - - 
  ADFI, lb 1.34 1.33 1.31 1.30 1.50 1.47 1.56 1.39 0.07 0.01 - - - 
  F/G 1.35 1.35 1.28 1.29 1.30 1.32 1.30 1.30 0.03 - - - - 
Overall, D 0 to 28              
  ADG, lb 0.67 0.68 0.67 0.66 0.76 0.75 0.81 0.68 0.04 0.01 - - - 
  ADFI, lb 0.89 0.88 0.85 0.85 0.96 0.95 1.02 0.88 0.05 0.01 0.08 0.04 - 
  F/G 1.32 1.30 1.27 1.28 1.27 1.28 1.26 1.31 0.02 - - - - 
D 28 to 35 (common diet)             
  ADG, lb 1.80 1.74 1.74 1.75 1.61 1.63 1.64 1.59 0.05 0.01 - - - 
  ADFI, lb 2.31 2.24 2.25 2.28 2.25 2.26 2.28 2.14 0.08 - - - - 
  F/G 1.28 1.29 1.29 1.30 1.41 1.39 1.39 1.35 0.03 0.01 - - - 
Overall, D 0 to 35              
  ADG, lb 0.90 0.89 0.88 0.88 0.93 0.92 0.98 0.85 0.04 0.07 0.10 0.09 - 
  ADFI, lb 1.17 1.15 1.13 1.13 1.22 1.21 1.27 1.12 0.05 0.01 0.07 0.04 - 
  F/G 1.30 1.29 1.28 1.28 1.31 1.31 1.30 1.32 0.02 0.04 - - - 
Pig Weights, lb              
  D 0 14.9 14.9 14.9 14.9 14.9 14.9 14.9 14.9 0.70 - - - - 
  D 14 19.7 20.1 19.3 19.3 20.3 20.2 20.6 19.3 1.04 0.05 0.13 0.05 - 
  D 28 33.7 33.8 33.6 33.5 36.5 36.4 37.5 35.1 1.62 0.01 - - - 
  D 35 46.3 46.0 45.8 45.7 47.7 47.8 49.0 46.2 1.81 0.01 - - - 
aA total of 288 pigs were used in a 35-day experiment with eight replications and 4 or 5 pigs per pen. Experimental diets were fed in two phases, with 
phase 1 from d 0 to 14 after weaning and phase 2 from d 14 to 28. A common diet containing an antibiotic (Neo-Terramycin with 140 g of neomycin and 
140 g of oxytetracycline per ton) was fed during the third phase from d 28 to 35. 
bThe negative control diet did not contain a feed-grade antibiotic. The positive control diet contained a feed-grade antibiotic (Neo-Terramycin with 140 g 
of neomycin and 140 g of oxytetracycline per ton). 
cNo interactions, P>0.10 
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Table 3.  Growth Performance of Nursery Pigs Fed Increasing Arabinogalactan – Main Effectsa,b,c
P <       
 Control  Arabinogalactan, %   Arabinogalactan 
Item Negative Positive 0 0.05 0.10 0.20 SE Mean 
Negative vs 
Positive Arabinogalactan Linear Quadratic 
D 0 to 14            
  ADG, lb 0.34 0.37 0.36 0.38 0.36 0.31 0.04 0.08 0.10 0.05 - 
  ADFI, lb 0.41 0.44 0.44 0.43 0.43 0.39 0.03 0.08 0.06 0.02 - 
  F/G 1.26 1.29 1.26 1.20 1.22 1.42 0.15 - - - - 
D 14 to 28            
  ADG, lb 1.00 1.14 1.08 1.05 1.11 1.04 0.05 0.01 - - - 
  ADFI, lb 1.32 1.48 1.42 1.40 1.44 1.34 0.07 0.01 - - - 
  F/G 1.32 1.30 1.32 1.33 1.29 1.30 0.03 - - - - 
Overall, D 0 to 28            
  ADG, lb 0.67 0.75 0.72 0.71 0.74 0.67 0.04 0.01 - - - 
  ADFI, lb 0.86 0.95 0.93 0.91 0.93 0.86 0.05 0.01 0.08 0.04 - 
  F/G 1.29 1.28 1.29 1.29 1.27 1.29 0.02 - - - - 
D 28 to 35 (common diet)           
  ADG, lb 1.76 1.62 1.70 1.68 1.69 1.67 0.05 0.01 - - - 
  ADFI, lb 2.27 2.23 2.28 2.25 2.27 2.21 0.08 - - - - 
  F/G 1.29 1.38 1.34 1.34 1.34 1.33 0.03 0.01 - - - 
Overall, D 0 to 35            
  ADG, lb 0.89 0.92 0.91 0.91 0.93 0.87 0.04 0.07 0.10 0.09 - 
  ADFI, lb 1.15 1.21 1.19 1.18 1.20 1.13 0.05 0.01 0.07 0.04 - 
  F/G 1.29 1.31 1.31 1.30 1.29 1.30 0.02 0.04 - - - 
Pig Weights, lb            
  D 0 14.9 14.9 14.9 14.9 14.9 14.9 0.70 - - - - 
  D 14 19.6 20.1 20.0 20.1 20.0 19.3 1.04 0.05 0.13 0.05 - 
  D 28 33.7 36.4 35.1 35.1 35.6 34.3 1.62 0.01 - - - 
  D 35 46.0 47.7 47.0 46.9 47.4 46.0 1.81 0.01 - - - 
aA total of 288 pigs were used in a 35-day experiment with eight replications and 4 or 5 pigs per pen. Experimental diets were fed in two phases, with 
phase 1 from d 0 to 14 after weaning and phase 2 from d 14 to 28. A common diet containing an antibiotic (Neo-Terramycin with 140 g of neomycin and 
140 g of oxytetracycline per ton) was fed during the third phase from d 28 to 35. 
bThe negative control diet did not contain a feed-grade antibiotic. The positive control diet contained a feed-grade antibiotic (Neo-Terramycin with 140 g 
of neomycin and 140 g of oxytetracycline per ton). 
cNo interactions, P>0.10 
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